Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.

JAMA Ophthalmology
Rupesh AgrawalCollaborative Ocular Tuberculosis Study (COTS)–1 Study Group

Abstract

Eradication of systemic tuberculosis (TB) has been limited by neglected populations and the HIV pandemic. Whereas ocular TB often presents as uveitis without any prior evidence of systemic TB, the existing uncertainty in the diagnosis of TB uveitis may perpetuate missed opportunities to address systemic TB. To examine the clinical features of TB uveitis and the associations with response to antitubercular therapy (ATT). This retrospective multinational cohort study included patients from 25 ophthalmology referral centers diagnosed with TB uveitis and treated with ATT from January 1, 2004, through December 31, 2014, with a minimum follow-up of 1 year. Treatment failure, defined as a persistence or recurrence of inflammation within 6 months of completing ATT, inability to taper oral corticosteroids to less than 10 mg/d or topical corticosteroid drops to less than 2 drops daily, and/or recalcitrant inflammation necessitating corticosteroid-sparing immunosuppressive therapy. A total of 801 patients (1272 eyes) were studied (mean [SD] age, 40.5 [14.8] years; 413 [51.6%] male and 388 [48.4%] female; 577 [73.6%] Asian). Most patients had no known history (498 of 661 [75.3%]) of systemic TB. Most patients had bilateral involvement (471...Continue Reading

Citations

Sep 1, 2018·Current Opinion in Ophthalmology·Wipada Laovirojjanakul, Onsiri Thanathanee
Nov 6, 2018·Ocular Immunology and Inflammation·Victor LlorençAlfredo Adán
Apr 12, 2019·JAMA Ophthalmology·Ling Chen
Jan 19, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah A McGuffinElizabeth R Duke
Nov 26, 2019·Ocular Immunology and Inflammation·Ilaria TestiVishali Gupta
Sep 8, 2019·Journal of Clinical Medicine·Vittorio PiraniCesare Mariotti
Mar 13, 2020·Ocular Immunology and Inflammation·Ilaria TestiVishali Gupta
Apr 7, 2020·Ocular Immunology and Inflammation·Rupesh AgrawalVishali Gupta
Apr 23, 2020·Ocular Immunology and Inflammation·Dinesh Visva GunasekeranUNKNOWN Collaborative Ocular Tuberculosis Study (COTS) Group
May 15, 2020·Ocular Immunology and Inflammation·Soumyava BasuPaul Elkington
Jul 1, 2020·Ocular Immunology and Inflammation·Rupesh AgrawalVishali Gupta
Jul 10, 2020·Ocular Immunology and Inflammation·Prabhjot Kaur MultaniSoumyava Basu
Aug 19, 2020·Ocular Immunology and Inflammation·Salil MehtaVishali Gupta
Jan 4, 2020·Eye·Soumyava BasuUNKNOWN International Ocular TB Study Group
Jun 6, 2018·Infection·Luis AnibarroÁfrica González-Fernández
Oct 14, 2018·Eye·Aniruddha AgarwalVishali Gupta
Aug 23, 2020·Indian Journal of Ophthalmology·Rajesh RamanjuluMahesh P Shanmugam
Aug 19, 2018·Investigative Ophthalmology & Visual Science·Rupesh AgrawalUNKNOWN Collaborative Ocular Tuberculosis Study Group
Oct 20, 2018·Frontiers in Cellular and Infection Microbiology·Sudhanshu AbhishekIndu Verma
May 21, 2019·Ocular Immunology and Inflammation·L De SimoneL Cimino
Dec 11, 2019·Ocular Immunology and Inflammation·Rupesh AgrawalUNKNOWN Collaborative Ocular Tuberculosis Study (COTS) Group
Apr 17, 2020·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·Larissa Christina BrönnimannJustus Gerhard Garweg
Aug 23, 2020·Indian Journal of Ophthalmology·Samrat ChatterjeeAnupam Sahu
Oct 10, 2020·Frontiers in Psychiatry·Alton Ming Kai ChewDinesh Visva Gunasekeran
Sep 26, 2020·Ocular Immunology and Inflammation·Aniruddha AgarwalVishali Gupta
Jan 9, 2021·Ocular Immunology and Inflammation·Mamta AgarwalManfred Zierhut
Jan 12, 2021·Clinical & Experimental Ophthalmology·Bjorn Kaijun BetzlerRupesh Agrawal
Jan 21, 2021·The British Journal of Ophthalmology·Alessandro MarcheseGiuseppe Casalino
Jan 30, 2021·Asia-Pacific Journal of Ophthalmology·Anamika PatelSoumyava Basu
Feb 2, 2021·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Tingting JiangQing Chang
Nov 18, 2020·Tuberculosis·Rupesh AgrawalCarlos Pavesio
Feb 3, 2021·American Journal of Ophthalmology·Aniruddha AgarwalVishali Gupta
Nov 25, 2020·International Journal of Dermatology·Lamia S Al AkrashRuaa Al Harithy
Oct 5, 2020·Tuberculosis·Soumyava BasuNarsing A Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.